(Q36010484)

11 August 2017

Amyloid-β associated volume loss occurs only in the presence of phospho-tau (English)

1 reference

Alzheimer's Disease Neuroimaging Initiative

11 August 2017

series ordinal

11

object named as

Alzheimer’s Disease Neuroimaging Initiative

1 reference

11 August 2017

6

Kaj Blennow

1 reference

11 August 2017

10

Anders M Dale

1 reference

11 August 2017

4

Dominic Holland

1 reference

11 August 2017

9

Bradley T Hyman

1 reference

11 August 2017

7

Paul S Aisen

1 reference

11 August 2017

1

Rahul S Desikan

1 reference

11 August 2017

2

Linda K McEvoy

1 reference

11 August 2017

Wesley K Thompson

3

1 reference

PMCID

3368003

11 August 2017

J Cooper Roddey

series ordinal

5

1 reference

PMCID

3368003

11 August 2017

James B Brewer

series ordinal

8

1 reference

11 August 2017

14 October 2011

1 reference

11 August 2017

1 reference

11 August 2017

70

1 reference

11 August 2017

4

1 reference

11 August 2017

657-661

1 reference

Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Preservation of neuronal number despite age-related cortical brain atrophy in elderly subjects without Alzheimer disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Impaired spine stability underlies plaque-related spine loss in an Alzheimer's disease mouse model

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3368003

Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks

2 October 2017

1 reference

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

21 January 2018

1 reference

CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.

21 January 2018

1 reference

CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

21 January 2018

1 reference

Nonlinear registration of longitudinal images and measurement of change in regions of interest

21 January 2018

1 reference

Amyloid-β associated cortical thinning in clinically normal elderly

21 January 2018

1 reference

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22002658

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22002658

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/ANA.22509

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

PMCID

3368003